Translational Research Cancer Centers Consortium
The Translational Research Cancer Centers Consortium (TRCCC) mission is to gain a greater understanding of the interactions between the immune system and cancer in the setting of biologic therapy of cancer.
TRCCC was initiated in 1998 to expedite the progress in immunotherapy and other biologic therapies. The organization has successfully brought together leaders in this field to advance science, collaboration, and clinical trials to help individuals diagnosed with cancer.
TRCCC 26th Meeting
The SITC Sponsored Session on Gender in Science and Academia will take place on Friday, February 23rd from 10-11 a.m. and will be followed by the SITC sponsored postdoc symposium from 11 a.m. - 12:30 p.m.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com